TIL · CIK 0001789769 · FY2025 live · 2025-12-31
Instil Bio, Inc.
View as
Model
Classic Z
FY2025
−4.41
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−4.41
Z″ −6.88
Score −4.41 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.921.2 × = 1.10X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−3.571.4 × = −5.00X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.393.3 × = −1.27X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.270.6 × = 0.76X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Instil Bio, Inc. is on classic Z at −4.41 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 33rd percentile in Healthcare.
- ANNXDistressAnnexon, Inc.−4.41
- MENSDistressJyong Biotech Ltd.−4.40
- RLMDDistressRELMADA THERAPEUTICS, INC.−4.43
- AQSTDistressAquestive Therapeutics, Inc.−4.43
- RAREDistressUltragenyx Pharmaceutical Inc.−4.44
- CYTKDistressCYTOKINETICS INC−4.37
- SNDXDistressSyndax Pharmaceuticals Inc−4.35
- IRWDDistressIRONWOOD PHARMACEUTICALS INC−4.48
KPI widgets
Current assets
$191M
Total assets
$204M
Current liabilities
$5M
Total liabilities
$90M
Working capital
$187M
Retained earnings
−$726M
EBIT
−$79M
Total sales
$0
Book equity
$114M
Accession 0001789769-26-000019. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.